Overview
Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic collaboration.
Why Attend?
Discover actionable, in-depth programming curated by industry professionals, brought to you by the leading life sciences law firm. Gain invaluable insights into the most pressing transactional trends and developments shaping the life sciences deal market.
Connect with the best in the field.
Rub shoulders with senior-level decision-makers you want to meet, including C-suite executives, general counsel, deal lawyers, senior business development executives, investors, founders, and other strategy leaders.
Hear from innovation-driven speakers.
Hear from industry veterans including keynote speaker, Paul Hastings, the Immediate Past Chair of the Biotechnology Innovation Organization (BIO) and President and Chief Executive Officer of Nkarta, Inc., a leading cell therapy company combatting cancer with natural killer (NK) immune cells.
This year’s Life Sciences Dealmaking Symposium is not to be missed! We hope you can join us in Boston.